India In Vitro Diagnostics Market Size Expected to Reach USD 10.2 Billion by 2034 at a CAGR of 6.63%

Introduction

According to IMARC Group's report titled "India In Vitro Diagnostics Market Size, Share, Trends and Forecast by Test Type, Product, Usability, Application, End User, and Region, 2026-2034" the report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights.

How Big is the India In Vitro Diagnostics Market?

The India in vitro diagnostics market size reached USD 5.6 Billion in 2025 and is expected to reach USD 10.2 Billion by 2034, exhibiting a CAGR of 6.63% during the forecast period from 2026 to 2034.

The market growth is driven by the rising incidence of chronic diseases such as diabetes, cardiovascular diseases, and cancer which increases demand for early diagnosis and monitoring tests.

Evaluate Market Opportunity with the Business Sample Report: https://www.imarcgroup.com/india-in-vitro-diagnostics-market/requestsample

What are the Latest Emerging Trends in India In Vitro Diagnostics Market?

• Rising Adoption of Point-of-Care Testing:

Point-of-care diagnostic solutions are gaining traction due to faster results, improved accessibility, and growing demand for decentralized healthcare, particularly across clinics, emergency settings, and rural healthcare infrastructure.

• Growing Demand for Molecular Diagnostics:

Increasing prevalence of infectious diseases and chronic conditions is accelerating adoption of molecular diagnostics, including PCR-based testing, enabling early disease detection, improved treatment decisions, and enhanced laboratory accuracy.

• Expansion of Preventive Health Screening:

Preventive healthcare awareness is encouraging routine diagnostic testing for diabetes, cardiovascular diseases, and cancer biomarkers. Additionally, corporate wellness programs and health packages are boosting demand for diagnostic services.

What Growth Factors are Driving India In Vitro Diagnostics Market?

• Rising Burden of Chronic and Infectious Diseases:

Growing incidence of diabetes, cardiovascular disorders, and infectious diseases is driving demand for diagnostic testing, encouraging hospitals and laboratories to expand testing capabilities and invest in advanced diagnostic technologies.

• Increasing Healthcare Infrastructure Development:

Expansion of diagnostic laboratories, hospital networks, and pathology chains across tier-2 and tier-3 cities is improving accessibility. Moreover, investments in automated diagnostic equipment are supporting faster and accurate testing services.

• Technological Advancements in Diagnostic Platforms:

Automation, AI-enabled analytics, and high-throughput analyzers are improving laboratory efficiency and reducing turnaround time. In addition, digital integration and cloud-based reporting are enhancing diagnostic workflow and patient management.

India In Vitro Diagnostics Market - Recent News

• In September 2025, India launched the In-Vitro Diagnostics (IVD) validation portal at the National Virus Research & Diagnostic Laboratory (VRDL) Conclave to enhance IVD validation efficiency and transparency.
• In August 2025, the CDSCO and ICMR issued draft evaluation protocols for 15 IVD types including Dengue, Malaria, and SARS-CoV-2, inviting feedback until August 25, 2025.
• In September 2024, Fapon showcased innovative IVD solutions at Medical Fair India 2024 in Mumbai, offering new biomarkers, reagents, and open-instrument platforms to strengthen the Indian IVD industry.

India In Vitro Diagnostics Market Segmentation:

Test Type Insights:

• Clinical Chemistry
• Molecular Diagnostics
• Immunodiagnostics
• Hematology
• Others

Product Insights:

• Reagents and Kits
• Instruments

Usability Insights:

• Disposable IVD Devices
• Reusable IVD Devices

Application Insights:

• Infectious Disease (24.6%)
• Diabetes
• Cancer/Oncology
• Cardiology
• Autoimmune Disease
• Nephrology
• Others

Regional Insights:

• North India
• West and Central India
• South India
• East and Northeast India

The North India region leads the market with the largest share, supported by advanced healthcare infrastructure and high diagnostic service demand. The overall market is forecasted to grow at a CAGR of 6.63% during 2026-2034.

Key Highlights of the Report

• Comprehensive quantitative analysis of the India in vitro diagnostics market from 2020-2034.
• Detailed insights into market drivers, challenges, opportunities, and segment-wise assessments.
• Porter's five forces analysis to evaluate competitive dynamics and industry attractiveness.
• Extensive competitive landscape with key player positioning and strategic insights.
• Regional market analysis covering North, West and Central, South, and East and Northeast India.

Competitive landscape:

The report offers an in-depth examination of the competitive landscape, including market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.

Get Custom Report Based on Your Interest: https://www.imarcgroup.com/request?type=report&id=21465&flag=E

Customization Note: If you require any specific information not covered within this report's scope, we will provide it as part of the customization.

Frequently Asked Questions:

1. What was the size of the India in vitro diagnostics market in 2025?
➤ The India in vitro diagnostics market was valued at USD 5.6 Billion in 2025.

2. What will the India in vitro diagnostics market be worth by 2034?
➤ The India in vitro diagnostics market is anticipated to reach a value of USD 10.6 Billion by 2034.

3. What factors are driving growth in the India in vitro diagnostics market?
➤ Growth is driven by rising disease burden, higher healthcare spending, domestic manufacturing incentives, and expanding molecular and POCT testing.

4. Who are the key players in the India in vitro diagnostics market?
➤ Key players include Roche, Abbott, Siemens Healthineers, Transasia, Thermo Fisher, Sysmex, Molbio, and Mylab.

5. What challenges does the India in vitro diagnostics market face?
➤ Challenges include regulatory complexity, import dependence, skilled workforce shortages, pricing pressure, and limited reimbursement coverage.

Get Sample of Our Latest In-Depth Reports On Related Topics:

✤ Indian Diagnostic & Therapeutic Antibodies Market: https://www.imarcgroup.com/antibodies-market-india/requestsample

✤ India Biologics Market: https://www.imarcgroup.com/india-biologics-market/requestsample

✤ India Digital Health Market: https://www.imarcgroup.com/india-digital-health-market/requestsample

✤ India Hospital Market: https://www.imarcgroup.com/india-hospital-market/requestsample

✤ India Respiratory Inhalers Market: https://www.imarcgroup.com/india-respiratory-inhalers-market/requestsample

Contact Us

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel: (D) +91 120 433 0800
United States: +1-201971-6302

About Us

IMARC Group is a global management consulting firm that helps ambitious changemakers create a lasting impact. The company offers comprehensive market assessment, feasibility studies, incorporation support, regulatory assistance, branding and strategy services, and procurement research.

This release was published on openPR.